Evidence map›Paper›PMID 21969816›Full record

ArticleNeoplasia (New York, N.Y.)2011

Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

Paula A Agudelo-Garcia, Jessica K De Jesus, Shante P Williams, Michal O Nowicki, Ennio Antonio Chiocca, Sandya Liyanarachchi, Pui-Kai Li, John J Lannutti, Jed K Johnson, Sean E Lawler and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04325789 (A Prospective Randomized Multicenter Evaluation of Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years), which is not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04325789 nacompletednot on this mapstarted 2020, after this paper: background citation

A Prospective Randomized Multicenter Evaluation of Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years

TypeinterventionalSponsorAtreon OrthopedicsRan2020 to 2025Enrolled91ConditionsRotator Cuff Tears, Full-thickness Rotator Cuff TearsArmsnanofiber scaffold
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 133 citations in OpenAlex.

  1. High glucose enhances NScientific reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Nanofiber curvature with Rho GTPase activity increases mouse embryonic fibroblast random migration velocity.Integrative biology : quantitative biosciences from nano to macro · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.International journal of molecular sciences · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Paula A Agudelo-GarciaCenter for Molecular Neurobiology, The Ohio State University, Columbus, OH 43210, USA.
Jessica K De Jesus
Shante P Williams
Michal O Nowicki
Ennio Antonio Chiocca
Sandya Liyanarachchi
Pui-Kai Li
John J Lannutti
Jed K Johnson
Sean E Lawler
Mariano S Viapiano
The Ohio State University · USThe Ohio State University Wexner Medical Center · USNeurological Surgery · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
Targeting the Tumor Matrix as Anti-Invasive and Sensitizing Strategy for GliomaR01CA152065 · NCI · OHIO STATE UNIVERSITY · PI VIAPIANO, MARIANO SEBASTIAN · 2010 to 2014
$1.3M
High-Throughput Ex Vivo Tumor Cell Motility AssayR43CA150763 · NCI · NANOFIBER SOLUTIONS, LLC · PI JOHNSON, JED KIZER · 2010 to 2010
$199k
NCI NIH HHS 1R01CA152065-01NCI NIH HHS 1R43CA150763-01NCI NIH HHS R01 CA152065NCI NIH HHS R43 CA150763NCRR NIH HHS UL1 RR025755
6 · The paper itself

Abstract

A hallmark of malignant gliomas is their ability to disperse through neural tissue, leading to long-term failure of all known therapies. Identifying new antimigratory targets could reduce glioma recurrence and improve therapeutic efficacy, but screens based on conventional migration assays are hampered by the limited ability of these assays to reproduce native cell motility. Here, we have analyzed the motility, gene expression, and sensitivity to migration inhibitors of glioma cells cultured on scaffolds formed by submicron-sized fibers (nanofibers) mimicking the neural topography. Glioma cells cultured on aligned nanofiber scaffolds reproduced the elongated morphology of cells migrating in white matter tissue and were highly sensitive to myosin II inhibition but only moderately affected by stress fiber disruption. In contrast, the same cells displayed a flat morphology and opposite sensitivity to myosin II and actin inhibition when cultured on conventional tissue culture polystyrene. Gene expression analysis indicated a correlation between migration on aligned nanofibers and increased STAT3 signaling, a known driver of glioma progression. Accordingly, cell migration out of glioblastoma-derived neurospheres and tumor explants was reduced by STAT3 inhibitors at subtoxic concentrations. Remarkably, these inhibitors were ineffective when tested at the same concentrations in a conventional two-dimensional migration assay. We conclude that migration of glioma cells is regulated by topographical cues that affect cell adhesion and gene expression. Cell migration analysis using nanofiber scaffolds could be used to reproduce native mechanisms of migration and to identify antimigratory strategies not disclosed by other in vitro models.

Indexed as

Cell MovementActinsAnimalsAnthraquinonesBrain NeoplasmsCell AdhesionCell Line, TumorCell Migration AssaysCyclic S-OxidesGene ExpressionGliomaHumansMiceMyosin Type IINanofibersNeoplasm InvasivenessActinsAnthraquinonesCyclic S-OxidesLLL12 compoundMyosin Type IIPolystyrenesSTAT3 protein, humanSTAT3 Transcription FactorstatticSulfonamides

Identifiers

PMID21969816
PMCPMC3182275
OpenAlexW1916854011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.